Discover key insights from ADC Therapeutics' Q4 2024 earnings call, including ZYNLONTA’s commercial success, clinical trial updates, and strategic ...
Zacks Investment Research on MSN1d
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue EstimatesADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $1.03 per share a year ago. These figures ...
Analysts are estimating that ADC Therapeutics will report an earnings per share (EPS) of $-0.38. The announcement from ADC ...
On Saturday, April 5, the Murray County Fire Department and Emergency Management Agency will be giving away 225 Midland brand weather radios at no cost at the Bagley Middle School parking lot, 4600 ...
The Zionist group is one of many supporting calls by Trump to deport pro-Palestine students from the US. Several pro-Israel ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback